ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,501Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 2604

$554K Total Retail Price of All Prescriptions

Rank: 151 out of 2604

469 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 7,233 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 587 227 S3 1 1
SIMVASTATIN 445 314 2 2
LEVOTHYROXINE SODIUM 426 353 3 4
LISINOPRIL 398 304 4 3
FUROSEMIDE 242 193 5 8
OMEPRAZOLE 241 143 6 5
AMLODIPINE BESYLATE 235 163 7 6
MELOXICAM 215 133 8 36
METFORMIN HCL 200 126 9 7
METOPROLOL SUCCINATE 172 148 10 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 153 127 11 22
METHADONE HCL 152 23 S2 12 67
CITALOPRAM HBR 149 100 13 18
METFORMIN HCL ER 146 114 14 72
LANTUS 142 124 15 40
MORPHINE SULFATE ER 124 32 S2 16 58
CYMBALTA 119 61 17 44
DONEPEZIL HCL 116 116 18 28
GABAPENTIN 116 82 18 12
ACTOS 115 79 20 116
TRAMADOL HCL 115 97 20 15
METOPROLOL TARTRATE 115 88 20 9
ATENOLOL 115 75 20 11
GLIMEPIRIDE 108 68 24 57
POTASSIUM CHLORIDE 106 87 25 16
FENTANYL 94 41 S2 26 48
RANITIDINE HCL 85 77 27 25
LEVETIRACETAM 79 71 28 96
HYDROCHLOROTHIAZIDE 79 41 28 10
TAMSULOSIN HCL 76 56 30 30
ALENDRONATE SODIUM 75 66 31 29
PRAVASTATIN SODIUM 75 63 31 14
FLUOXETINE HCL 71 30 33 49
ZOLPIDEM TARTRATE 70 50 34 21
OLANZAPINE 64 45 35 115
NABUMETONE 60 45 36 197
LOVASTATIN 59 35 37 24
NAMENDA 57 46 38 37
LOSARTAN POTASSIUM 57 53 38 20
BACLOFEN 56 0 40 101
CLONIDINE HCL 55 53 41 56
RISPERIDONE 55 43 41 65
NOVOLOG 54 40 43 89
JANTOVEN 52 52 44 118
HUMALOG 52 51 44 203
PREDNISONE 51 39 46 34
CYCLOBENZAPRINE HCL 50 13 R 47 43
CARBAMAZEPINE 50 50 47 182
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.